A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

NCT03280550 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps
Chronic Rhinosinusitis

Interventions

DRUG: Omalizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche